Integrated Management of Acute and Chronic Cardiovascular Disease

Transcription

1 15 th International Meeting Integrated Management of Acute and Chronic Cardiovascular Disease ORGANIZERS: KURT HUBER (Austria) HARALD DARIUS (Germany) BERNARD GERSH (USA) OTMAR PACHINGER (Austria) under the auspices of Acute Cardiovascular Care Association A Registered Branch of the ESC MAIN TOPICS: Acute Coronary Syndromes Antiplatelet Agents Anticoagulants Atrial Fibrillation Biomarkers Case Presentations Coronary Artery Disease Devices: Coronary and Non-Coronary Heart Failure Interventional Cardiology Metabolic Syndrome Mitral Valve Repair Non-coronary Interventions Pulmonary Hypertension Renal Denervation TAVI Translational Science Innsbruck, Austria Austria Trend Congress Hotel January 25 28, 2014 PROGRAM

2 PREFACE This international meeting celebrates its 15 th anniversery. As in the past, the meeting is patronized by the ESC Working Group on Thrombosis, by the Acute Cardiovascular Care Association (ACCA), a registered branch of the ESC, and by the Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology (ATVB), Vienna, Austria. In 2014, more than 40 international and national experts will guarantee an interesting meeting with selected important topics by presenting the newest data in basic and clinical research, mainly in the field of acute coronary syndromes and atrial fibrillation with special focus on pharmacotherapy and device therapy. The number of attendees is limited to a maximum of 100 participants in order to stimulate intense discussions with international experts on case presentations and main topics a rare situation in our world of mega-congresses. The organizers will also invite the presenters of the best abstracts (a maximum of 30 abstracts will be accepted) to discuss their data with faculty members in moderated poster presentations. The best-ofbasic and best-of-clinical posters will be awarded with 3000 in total. This service will mainly refer to the group of young cardiologists of tomorrow. We hope to have raised your interest in participation in this outstanding meeting. With best regards Kurt Huber (For the organizers) DEADLINE FOR ABSTRACT SUBSTITUTION January 10, 2014 (send your abstracts directly to kurt.huber@meduniwien.ac.at) 1

3 Saturday, January 25, 2014 Arrivals 20:00 Welcome Cocktail 20:30 Get-Together-Evening Sunday, January 26, :45 Welcome K. Huber (AT) 09:00-11:00 Symposium I: Acute Cardiac Care in STEMI Joint Meeting with the Acute Cardiovascular Care Association (ACCA) chairs: K. Huber (AT), U. Zeymer (DE) 09:00 Case Presentation #1 (H. Alber, AT) 09:15 Local Application of Abciximab in STEMI (T. Neunteufl, AT) 09:35 Case Presentation #2 (R. Zimmerman, CDN) 09:50 The Present and Future Role of GPIs in Acute Coronary Syndromes (H. Schühlen, DE) 10:10 Case Presentation #3 (R. Zimmerman, CDN) 10:25 Optimal Duration of DAPT after ACS (S. Kristensen, DK) 10:45 Case Presentation #4 (S. Harb, AT) 11:00-11:30 Break, Exhibition 2

4 Sunday, January 26, :30-12:30 Special Symposium 1: Biomarkers in Ischemic Heart Disease (supported by Brahms/ThermoFisher) moderator: H. Darius (DE) 11:30 Copeptin for Rule out of Myocardial Infarction (M. Möckel, DE) 12:00 New Biomarkers in Ischemic Heart Disease Scientific Tools Only or Soon for Routine Use? (C. Müller, CH) 12:30-13:30 Lunch Break, Exhibition, Basic Research Posters (moderation: J. Wojta, AT, D. Gulba, DE) 13:30-14:30 Special Symposium 2: Dabigatran Actual Data and Practical Aspects (supported by Boehringer Ingelheim) moderator: K. Huber (AT) 13:30 Perioperative Management and Opportunities for Testing (S. Kozek-Langenecker, AT) 14:00 Dabigatran in Stroke Prophylaxis: Facts and Clinical Practice (H. Darius, DE) 14:30-15:30 Symposium II: Master Lectures chairs: C. Granger (US), M. Möckel (DE) 14:30 Pulmonary Hypertension Recent Advances (Irene Lang, AT) 14:50 Coronary Rotablation Is It There To Stay? (G. Gaul, AT) 15:10 Stroke Prevention in Patients with Atrial Fibrillation and ACS: A Narrow Window of Opportunity (C. Granger, US) 15:30-16:00 Break, Exhibition 3

5 Sunday, January 26, :00-17:20 Symposium III: Heart Failure chairs: S. James (SE), O. Pachinger (AT) 16:00 Case Presentation #5 (Valerie Weihs, AT) 16:15 Revascularization in Chronic HF: Is There Still a Role for Viability and Ischemia Testing? (B. Gersh, USA) 16:40 Case Presentation #6 (J. Riedl, AT) 16:55 New Evidence Might Change Current Guidelines in Heart Failure (F. Ruschitzka, CH) 17:20-17:35 Break, Exhibition 17:35-19:05 Symposium IV: Acute Coronary Syndromes Joint Meeting with the WG on Thrombosis of the ESC chairs: D. Gulba (DE), J. Wojta (AT) 17:35 Vorapaxar in CAD A Future Therapeutic Option? (H. Darius, DE) 18:00 Modern Antithrombotic Therapy What Is in the Pipelines? (R. De Caterina, IT) 18:25 ACS Risk Stratification for Atherothrombotic Events and Bleeding (K.A.A. Fox, UK) 18:40 Multivessel PCI or Culprit Lesion Only in Acute ST-Elevation Myocardial Infarction (H. Thiele, DE) 20:00 Faculty Dinner 4

6 Monday, January 27, :00-11:00 Symposium V: New Antithrombotic Strategies in Cardiovascular Disease chairs: S. Kristensen (DK), W.-M. Franz (AT) 09:00 Direct Oral Anticoagulants: Once Daily or Twice Daily? (R. De Caterina, IT) 09:25 Case Presentation #7 (H. Schuchlenz, AT) 09:40 Edoxaban in Atrial Fibrillation: The ENGAGE Trial (F.W.A. Verheugt, NL) 10:05 Case Presentation #8 (H. Alber, AT) 10:20 Pre-hospital Antithrombotic Strategies in Patients with ACS: Still Important? (G. Montalescot, FR) 10:45 Case Presentation #9 (G. Friedrich, AT) 11:00-11:30 Break, Exhibition 11:30-12:30 Special Symposium 3: New Concepts for Improved Patient Outcomes (supported by Biosensors) moderator: H. Thiele (DE) 11:30 Case Presentation #10 (H. Sipötz, AT) 11:40 The Biosensors Stent Family Clinical Experience (P. Clemmensen, DK) 12:00 Case Presentation #11 (G. Christ, AT) 12:10 Rationale and Design of the GLOBAL LEADERS Trial (K. Huber, AT) 12:30-13:30 Lunch Break, Exhibition, Clinical Research Posters (moderators: S. Kristensen (DK), B. Meier (CH) 5

7 Monday, January 27, :30-14:30 Special Symposium 4: Antiplatelet Therapy Revisited (supported by Daiichi Sankyo & Eli Lilly) moderator: Irene Lang (AT) 13:30 Abciximab Does it Still Have a Role? (H. Schühlen, DE) 13:50 Prasugrel Where Do We Stand? (K. Huber, AT) 14:10 Platelet Function Measurement & Genetic Profiling in ACS: An Overview? (J.-P. Collet, FR) 14:30-15:30 Symposium VI: Ongoing Controversies chairs: G. Montalescot (FR), K.A.A. Fox (UK) 14:30 Intracoronary Imaging for Clinical Decision Making Pro: Julinda Mehilli (DE) Contra: U. Zeymer (DE) 15:00 Thrombolytic Therapy is Still Important in STEMI Networks Pro: F. Van de Werf (BE) Contra: P. Clemmensen (DK) 15: Break, Exhibition 16:00-17:00 Symposium VII: Bioabsorbable Vascular Scaffolds (BVS) (supported by Abbott Vascular) moderator: G. Christ (AT) 16:00 From Bioabsorbable Polymer-based Stent to Fully Bioabsorbable Vascular Scaffold (Julinda Mehilli, DE) 16:30 The ABSORB Stent Summary of Evidence and Potential Indications (G. Delle Karth, AT) 6

8 Monday, January 27, :00-18:15 Symposium VIII: Atrial Fibrillation chairs: O. Pachinger (AT), Sigrun Halvorsen (NO) 17:00 Biomarkers in Atrial Fibrillation (B. Gersh, US) 17:25 What Is Left for the Electrophysiologist in the Ablation Era? (M. Borggrefe, DE) 17:50 Practical Administration of the Novel DOACs (C. Granger, US) 18: Short Break, Coffee 18:30-19:30 Symposium IX: The Metabolic Syndrome in CV Disease chairs: H. Darius (DE), F. Ruschitzka (CH) 18:30 HDL-Increasing Strategies Do They Work? (R. De Caterina, IT) 18:50 Antibodies in Order To Reduce LDL-C: PCSK9 Inhibitors (H. Drexel, AT) 19:10 New Treatment Options for Diabetics: Of Advantage for the Cardiologic Patient? (T. Wascher, AT) 20:00 Networking Evening DEADLINE FOR ABSTRACT SUBSTITUTION January 10, 2014 (send your abstracts directly to 7

9 Tuesday, January 28, :00-10:00 Symposium IX: Non-Coronary Interventions chairs: U. Zeymer (DE), F. Van de Werf (BE) 09:00 TAVI An Update (S. Windecker, CH) 09:20 MitraClipping: Indications, Technique, Outcome (J. Aichinger, AT) 09:40 PFO, ASD and Left Atrium Appendix (B. Meier, CH) 10:00-11:00 Special Symposium 6: Antithrombotic Strategies of the Future (supported by The Medicines Company) moderator: P. Clemmensen (DK) 10:00 Bivalirudin in STEMI A Story of Success (K. Huber, AT) 10:30 Acute vs. Chronic Antithrombotic Management in ACS: Need for a Paradigm Shift? (S. James, SE) 11: Break, Exhibition 11:30-12:30 Special Symposium 7: Rivaroxaban The DOAC With Multiple Indications (supported by Bayer) moderator: O. Pachinger (AT) 11:30 In Deep Venous Thrombosis and Pulmonary Embolism (W. Sturm, AT) 11:50 In Atrial Fibrillation (K. Huber, AT) 12:10 In Secondary Prevention After ACS (H. Alber, AT) 12:30-13:30 Lunch Break, Exhibition, Clinical Research Posters (moderators: T. Weiss, AT, F. Ruschitzka, CH) 8

10 Tuesday, January 28, :30-14:30 Special Symposium 8: The Universal P2Y12- Antagonist (supported by AstraZeneca) moderator: S. Windecker (CH) 13:30 Ticagrelor: Should This Be Used Routinely? (S. James, SE) 14:00 Ongoing Trials and What We Might Expect (F.W.A. Verheugt, NL) 14:30-14:50 Invited Lecture moderator: C. Müller (CH) The Anti-Aldosterone-Strategy A New Important Therapeutic Option (G. Montalescot, FR) 14:50-15:40 Symposium X: Current and Future Developments chairs: M. Borggrefe (DE), S. Halvorsen (NO) 14:50 Indications for Revascularization in Patients with Stable CAD : Has This Been Overutilized? (B. Gersh, CDN) 15:15 Renal Denervation Still Great Expectations? (T. Weiss, AT) 15:40 Farewell (B. Gersh, US) 9

11 SPONSORS (per December 27, 2013) AstraZeneca 10

12 GENERAL INFORMATION Local Organisation Kurt Huber, MD, FESC, FACC Director, 3 rd Department of Medicine Cardiology & Emergency Medicine, Wilhelminenhospital Montleartstrasse 37, A-1160 Vienna, Austria Phone: (+43/1) , Fax: (+43/1) kurt.huber@wienkav.at Congress Secretariat Congress and Study Concept GesmbH Widerhoferplatz 4/3/19, A-1090 Vienna, Austria Contact: Ms. Mag. Franziska Beckmann Mobile: (+43)/(0) csconcept@chello.at Medical Exhibition and Advertising Medizinische Ausstellungs- und Werbegesellschaft Freyung 6, A-1014 Vienna, Austria Contact: Ms. Sonja Chmella Phone: (+43/1) , Fax: (+43/1) maw@media.co.at, Venue Austria Trend Hotel, Innsbruck Rennweg 12a, A-6020 Innsbruck Phone: (+43/512) , Fax: (+43/512) congress@austria-trend.at Congress Fee: 500. /250. (reduced fee for physicians in education) 2-day attendance: 300. / day attendance: 150. /100. Internet-Information: 11

13 NOTES 12

14 NOTES

15 INVITED FACULTY per November 11, 2013 International Faculty Martin BORGGREFE (Germany) Peter CLEMMENSEN (Denmark) Jean-Philippe COLLET (France) Raffaele DE CATERINA (Italy) Keith A.A. FOX (United Kingdom) Chris GRANGER (USA) Dietrich GULBA (Germany) Sigrun HALVORSEN (Norway) Stefan JAMES (Sweden) Steen KRISTENSEN (Denmark) Gilles MONTALESCOT (France) Julinda MEHILLI (Germany) Bernhard MEIER (Switzerland) Martin MÖCKEL (Germany) Christian MÜLLER (Switzerland) Frank RUSCHITZKA (Switzerland) Helmut SCHÜHLEN (Germany) Holger THIELE (Germany) Frans VAN DE WERF (Belgium) Freek VERHEUGT (The Netherlands) Stephan WINDECKER (Switzerland) Uwe ZEYMER (Germany) Rod ZIMMERMANN (Canada) Austrian Faculty Josef AICHINGER (LINZ) Hannes ALBER (Innsbruck) Günter CHRIST (Wien) Georg DELLE KARTH (Wien) Heinz DREXEL (Feldkirch) Wolfgang-Michael FRANZ (Innsbruck) Guy FRIEDRICH (Innsbruck) Georg GAUL (Wien) Stefan HARB (Graz) Irene LANG (Wien) Sibylle KOZEK-LANGENECKER (Wien) Thomas NEUNTEUFL (Wien) Johannes RIEDL (WIEN) Herwig SCHUCHLENZ (Graz) Johann SIPÖTZ (Wien) Wolfgang STURM (Innsbruck) Thomas WASCHER (Wien) Valerie WEIHS (Wien) Thomas WEISS (Wien) Johann WOJTA (Wien) Printed in Austria by: ROBIDRUCK A-1200 Vienna